Adamas got Orphan approval for LID. They have one
Post# of 30028
Posted On: 08/26/2015 9:37:21 PM
Adamas got Orphan approval for LID. They have one drug in phase 3 and another in phase 2. Market cap is $350M. Eltoprazine also has additional potential in ADHD and Alzheimer Aggression.
Shall we add MSPrecise next or Alzheimer Diagnostics?
Shall we add MSPrecise next or Alzheimer Diagnostics?
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼